SIGHT SCIENCES, INC. Deferred Tax Assets, in Process Research and Development
SIGHT SCIENCES, INC. (SGHT) had Deferred Tax Assets, in Process Research and Development of $4.57 million as of 2023-12-31, per its 10-K filed 2024-03-13.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2024-03-13
- 2023-12-31: Deferred Tax Assets, in Process Research and Development $4.57M.
- 2022-12-31: Deferred Tax Assets, in Process Research and Development $1.74M.
- 2021-12-31: Deferred Tax Assets, in Process Research and Development $0.00.
| Period end | Deferred Tax Assets, in Process Research and Development |
|---|---|
| 2023-12-31 | $4.57M 10-K · filed 2024-03-13 |
| 2022-12-31 | $1.74M 10-K · filed 2024-03-13 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |